The ink will be aimed initially at the biomedical market. Production quantities for commercial applications are anticipated in 2016 with leads already under evaluation, Haydale said.
Haydale has worked with the Taiwan-based firm to create a range of graphene-enhanced screen printable inks and pastes that can be rapidly altered to precisely suit customer needs.
Haydale will retain the exclusive rights to sell the developed inks into Europe, the Americas, Korea and Southeast Asia, while Dowton will have exclusive rights to sell the developed inks in its home market of The Republic of China (Taiwan) and also market the ink to existing customers in Japan and other territories.
Dowton has existing customer demand for conductive inks incorporating both carbon and metals (such as palladium, silver, copper and nickel), and will continue to sell existing products under its own Dowton brand.
The agreement is for an initial term of five years, but with an automatic roll-over unless one party serves six months' notice to terminate the agreement.
Ray Gibbs, chief executive of Haydale, said Dowton had helped Haydale to quickly, produce an excellent base conductive ink, or paste, that has been built on an existing Haydale product.
“The developed paste is specifically designed for the screen printing of bio-medical sensors, which is a substantial market, especially in the Far East. Even after 15 years of industry experience Dowton has expressed to us how surprised they were with the superior performance of our graphene-based paste and have stated they have customers ready to trial the product. We therefore anticipate revenues from this agreement during 2016,” Gibbs said.
"We like the way they do business," Gibbs told Proactive Investors. "Dowton move rapidly, their speed and quality are first class and speed is essential in a market place that needs to expand."
"Watch this space," teased Gibbs.
Shares were up 2.5% to 166p.
--ADD SHARE PRICE, CEO COMMENT--